Director Peter Maag sold 35,552 shares of CDNA for $1.2M across 3 transactions on 2024-08-20
Director Peter Maag executed 3 separate sales totaling 35,552 shares for $1,174,492.68 on 2024-08-20, reducing his holdings by 9.7% from 365,576 shares to 330,024 shares. The transactions occurred at prices ranging from $32.67 to $33.25, with a blended average of $33.04—above the current price of $30.96 but 8.9% below the 52-week high of $33.99. Notably, this sale occurs in the context of a company that reported negative net income ($-1.4M in the latest quarter), declining annual revenue growth of -12.9%, and unprofitability over the most recent full fiscal year. The 30-day and 90-day price appreciation (+63.0% and +94.2% respectively) establishes a materially elevated valuation backdrop for the transaction, contrasting sharply with the company's negative earnings trajectory.